---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-269949"
form_type: "8-K"
ticker: "FBRX"
cik: "0001419041"
company_name: "Forte Biosciences, Inc."
filed_at: "2024-12-03T23:59:59+00:00"
generated_at: "2026-05-29T09:42:36.691039+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Forte Biosciences hosts R&D Day focusing on FB102 autoimmune updates

## Summary
- R&D Day held December 3, 2024 highlighting FB102 development in autoimmune indications.
- Slide deck (Ex-99.1) and updated corporate presentation (Ex-99.2) furnished with the filing.
- No specific clinical data or financial guidance disclosed in the 8-K or exhibits.

## SEC filing metadata
- accession: 0001193125-24-269949
- form_type: 8-K
- ticker: FBRX
- cik: 0001419041
- company_name: Forte Biosciences, Inc.
- filed_at: 2024-12-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419041/000119312524269949/0001193125-24-269949-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419041/000119312524269949/d850569d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-269949
- JSON: https://secwatch.observer/filing/0001193125-24-269949.json
- Plain text: https://secwatch.observer/filing/0001193125-24-269949.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.